Live Breaking News & Updates on Tulane office of biosafety

Stay informed with the latest breaking news from Tulane office of biosafety on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tulane office of biosafety and stay connected to the pulse of your community

Tulane University to lead national research partnership to speed up COVID-19 vaccines and drug discoveries

The National Institutes of Health has selected Tulane National Primate Research Center to lead a new partnership between the seven federally funded National Primate Research Centers to combine their efforts to accelerate promising COVID-19 vaccine and drug research.
The NIH contract, awarded at $1.7 million for the first year, has the potential to reach up to $6.5 million over a four-year funding period.
Tulane will play a leading role in coordinating the evaluation of promising COVID-19 vaccines and therapeutics for COVTEN (Coronavirus Vaccine and Therapeutic Evaluation Network). The partnership will standardize research protocols and methods of data collection, share preliminary data and best practices across centers, and minimize the use of nonhuman primates by having single control groups across multiple studies. The centers, which normally conduct research independently, aim to harmonize their studies to provide more useful comparative data.

Oregon , United-states , Jay-rappaport , Angela-birnbaum , Nancy-haigwood , Paula-burch-celentano , Tulane-office-of-biosafety , Tulane-national-primate-research , National-institutes-of-health , Tulane-university , Tulane-national-primate-research-center , National-primate-research-centers